» Authors » Mara M Epstein

Mara M Epstein

Explore the profile of Mara M Epstein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 467
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Oyinbo A, Epstein M, Sabatino M, Liu S, Person S, Baek J, et al.
Cancer Epidemiol . 2024 Nov; 87:102483. PMID: 39492177
Background: The association between the Patient Protection and Affordable Care Act (ACA) and perceptions of health care quality of cancer survivors is not well established. The purpose of this study...
2.
Fisher K, Epstein M, Nguyen N, Fouayzi H, Crawford S, Linas B, et al.
J Comp Eff Res . 2024 Jul; 13(8):e230181. PMID: 39045844
To identify factors associated with willingness to participate in a COVID-19 clinical trial and reasons for and against participating. We surveyed Massachusetts (MA, USA) residents online using the Dynata survey...
3.
Cragun D, Salvati Z, Schneider J, Burnett-Hartman A, Epstein M, Hunter J, et al.
Genet Med . 2024 Jul; 26(10):101201. PMID: 38953292
Purpose: This study compared Lynch syndrome universal tumor screening (UTS) across multiple health systems (some of which had 2 or more distinct UTS programs) to understand multilevel factors that may...
4.
Fisher K, Mazor K, Epstein M, Goldthwait L, Abu Ghazaleh H, Zhou Y, et al.
Front Public Health . 2024 Jun; 12:1360341. PMID: 38873310
Introduction: The COVID-19 pandemic has been characterized by disparities in disease burden and medical care provision. Whether these disparities extend to long COVID awareness and receipt of medical care is...
5.
Castaneda-Avila M, Suarez-Ramos T, Torres-Cintron C, Epstein M, Gierbolini-Bermudez A, Tortolero-Luna G, et al.
Cancer Epidemiol . 2024 Jan; 89:102537. PMID: 38295555
Background: Multiple myeloma (MM) survival has increased during the last decades due to the introduction of new therapies. We investigated the intersectionality among age, sex, and race/ethnicity to better understand...
6.
Schneider J, Firemark A, Gille S, Davis J, Pawloski P, Liang S, et al.
Hered Cancer Clin Pract . 2023 Nov; 21(1):24. PMID: 37978552
Background: Lynch syndrome (LS) is the most common cause of inherited colorectal cancer (CRC). Universal tumor screening (UTS) of newly diagnosed CRC cases is recommended to aid in diagnosis of...
7.
Miller A, Yates J, Epstein M, Fantasia J, Frendl D, Afiadata A, et al.
Urol Pract . 2023 Aug; 4(2):126-131. PMID: 37592666
Introduction: Prostate specific antigen use in prostate cancer screening has undergone significant changes since the 2012 release of the USPSTF (United States Preventive Services Task Force) guideline statement. The effect...
8.
Salvati Z, Rahm A, Williams M, Ladd I, Schlieder V, Atondo J, et al.
Implement Sci Commun . 2023 Apr; 4(1):43. PMID: 37098602
Background: Identifying key determinants is crucial for improving program implementation and achieving long-term sustainment within healthcare organizations. Organizational-level complexity and heterogeneity across multiple stakeholders can complicate our understanding of program...
9.
Castaneda-Avila M, Baek J, Epstein M, Forrester S, Ortiz A, Lapane K
Womens Health Rep (New Rochelle) . 2023 Apr; 3(1):552-562. PMID: 37096019
Background: Research on the role of body size on cancer screening is mixed with few studies among Latinas in the United States. We evaluated the association between body size and...
10.
Castaneda-Avila M, Mazor K, Lapane K, Epstein M
Cancer Causes Control . 2023 Feb; 34(5):449-457. PMID: 36853428
Purpose: Monoclonal gammopathy of undetermined significance (MGUS) is the precursor of multiple myeloma. This qualitative study described patient (n = 14) experiences and healthcare providers' (n = 8) opinions and...